All antibody forms (polyclonal, hybridoma-based monoclonal and recombinant monoclonal) have advantages and disadvantages for development, validation and use. It depends on your project. Polyclonal antibodies are ideal reagents in assay-specific target discovery and detection. They display multi-epitope binding properties which make these reagents ideally suited for many applications. The clonal and biophysical diversity of polyclonal antibodies allows for greater sensitivity and utility in certain types of applications. And CUSABIO’s polyclonal antibodies should be on your reagents list.
CUSABIO polyclonal antibodies are all prepared with recombinant protein or native protein. Compared with peptide antibodies, affinity and specificity is superior. Moreover, there're more recognition of antigenic sites and have a much wider range of applications. Antibodies purified by affinity chromatography possess high purity.
As to quality control, CUSABIO proves the antibodies sensitivity and discriminating on natural proteins by rigorous ELISA test, and verify their specificity by Western blot test. It turns out that CUSABIO polyclonal antibodies have a broader scope of application and they a powerful tool for scientific research.
You will find more details on the images of validated applications.
CFHR5 Antibody (CSB-PA883624LA01HU)
STYX Antibody (CSB-PA851966LA01HU)
2-hydroxyisobutyryl-HIST1H1C (K109) Antibody (CSB-PA010378OA109hibHU)
2-hydroxyisobutyryl-HIST1H3A (K18) Antibody (CSB-PA010418PA18hibHU)
LGALS4 Antibody (CSB-PA012889LA01HU)
WDR73 Antibody (CSB-PA744047LA01HU)
TNFRSF1A Antibody (CSB-PA023977LA01HU)
UMODL1 Antibody (CSB-PA025617LA01HU)
Here is the catalog of all polyclonal antibodies. You can find the right ones for your research, or search them in the search box on the header part of this website.
If you can’t find the antibody you need in the catalog, please check CUSABIO Polyclonal Antibody Custom Service.
Product Name |
Code |
Species Reactivity |
Application |
Size |
---|---|---|---|---|
A29L Antibody |
CSB-PA46839LA01MPX | Monkeypox virus (strain Zaire-96-I-16) | ELISA, WB | 100μl/50μl |
DEFA6 Antibody |
CSB-PA980801GA01HU | Human | ELISA, WB, IHC | 100μl |
RPL28 Antibody, Biotin conjugated |
CSB-PA020217ED01HU | Human | ELISA, IHC | 100μg/50μg |
dcyD Antibody, Biotin conjugated |
CSB-PA18017D0Rb | Escherichia coli | ELISA, WB | 100μg/50μg |
HLA-DRB1 Antibody, Biotin conjugated |
CSB-PA17949D0Rb | Human | ELISA, IHC | 100μg/50μg |
HLA-C Antibody, Biotin conjugated |
CSB-PA15099D0Rb | Human | ELISA, IHC | 100μg/50μg |
HLA-B Antibody, Biotin conjugated |
CSB-PA15089D0Rb | Human | ELISA, IHC | 100μg/50μg |
APX2 Antibody, HRP conjugated |
CSB-PA14419B0Rb | Arabidopsis thaliana | ELISA, WB | 100μg/50μg |
YWHAH Antibody, Biotin conjugated |
CSB-PA02174D0Rb | Human | ELISA, IHC | 100μg/50μg |
AP1S3 Antibody, Biotin conjugated |
CSB-PA001868ED01HU | Human | ELISA, IHC | 100μg/50μg |
Anxa1 Antibody, HRP conjugated |
CSB-PA001836YB01MO | Mouse, Human | ELISA, WB | 100μg/50μg |
TMPRSS2 Antibody |
CSB-PA971239 | Human | ELISA, WB | 100μl/50μl |
S100A8 Antibody |
CSB-PA020641GA01HU | Human,Mouse,Rat | ELISA,WB,IHC | 100μl |
CYR61 Antibody |
CSB-PA940403 | Human,Mouse,Rat | WB, ELISA | 100μg/50μg |
S Antibody, Biotin conjugated |
CSB-PA33245YD11GMY | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA | 100μl/50μl |
S Antibody, FITC conjugated |
CSB-PA33245YC11GMY | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | 100μl/50μl | |
S Antibody, HRP conjugated |
CSB-PA33245YB11GMY | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA | 100μl/50μl |
S Antibody |
CSB-PA33245YA11GMY | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA | 100μl/50μl |
S Antibody, Biotin conjugated |
CSB-PA33245YD01GMY | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA | 100μl/50μl |
S Antibody |
CSB-PA33245YA01GMY | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA | 100μl/50μl |
SPARCL1 Antibody |
CSB-PA945237 | Human, Mouse, Rat | WB, ELISA: WB:1:500-2000, ELISA:1:5000-20000 | 100μg/50μg |
ABHD10 Antibody |
CSB-PA591994 | Human, Rat | WB ,ELISA | 100μg/50μg |
N Antibody, HRP conjugated |
CSB-PA33254B0Rb | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | ELISA, WB | 100ul/50ul |
N Antibody |
CSB-PA33254A0Rb | Human Novel Coronavirus (SARS-CoV-2/ 2019-nCoV) | WB, ELISA | 100ul/50ul |
HLA-G Antibody, Biotin conjugated |
CSB-PA010509LD01HU | Human | ELISA | 100μl/50μl |
GCG Antibody, Biotin conjugated |
CSB-PA009315LD11HU | Human | ELISA | 100μl/50μl |
FST Antibody, HRP conjugated |
CSB-PA009024LB01HU | Human | ELISA | 100μl/50μl |
CLDN11 Antibody, FITC conjugated |
CSB-PA005492LC11HU | Human | 100μl/50μl | |
CA9 Antibody, Biotin conjugated |
CSB-PA614990LD01HU | Human | ELISA | 100μl/50μl |
Apoa1 Antibody, Biotin conjugated |
CSB-PA001913LD01RA | Rat | ELISA | 100μl/50μl |
YAP1 Antibody, Biotin conjugated |
CSB-PA026244LD11HU | Human | ELISA | 100μl/50μl |
YAP1 Antibody, FITC conjugated |
CSB-PA026244LC11HU | Human | 100μl/50μl | |
YAP1 Antibody, HRP conjugated |
CSB-PA026244LB11HU | Human | ELISA | 100μl/50μl |
YAP1 Antibody |
CSB-PA026244LA11HU | Human | ELISA, WB, IF | 100μl/50μl |
YAP1 Antibody, Biotin conjugated |
CSB-PA026244LD01HU | Human | ELISA | 100μl/50μl |
YAP1 Antibody, FITC conjugated |
CSB-PA026244LC01HU | Human | 100μl/50μl | |
YAP1 Antibody, HRP conjugated |
CSB-PA026244LB01HU | Human | ELISA | 100μl/50μl |
YAP1 Antibody |
CSB-PA026244LA01HU | Human | ELISA, IHC, IF | 100μl/50μl |
VPS26A Antibody, Biotin conjugated |
CSB-PA025898LD11HU | Human | ELISA | 100μl/50μl |
VPS26A Antibody, FITC conjugated |
CSB-PA025898LC11HU | Human | 100μl/50μl | |
VPS26A Antibody, HRP conjugated |
CSB-PA025898LB11HU | Human | ELISA | 100μl/50μl |
VPS26A Antibody |
CSB-PA025898LA11HU | Human | ELISA, IHC | 100μl/50μl |
VPS26A Antibody, Biotin conjugated |
CSB-PA025898LD01HU | Human | ELISA | 100μl/50μl |
VPS26A Antibody, FITC conjugated |
CSB-PA025898LC01HU | Human | 100μl/50μl | |
VPS26A Antibody, HRP conjugated |
CSB-PA025898LB01HU | Human | ELISA | 100μl/50μl |
VPS26A Antibody |
CSB-PA025898LA01HU | Human | ELISA, IHC | 100μl/50μl |
TMEM37 Antibody, Biotin conjugated |
CSB-PA820182ND01HU | Human | ELISA | 100μl/50μl |
TMEM37 Antibody, FITC conjugated |
CSB-PA820182NC01HU | Human | 100μl/50μl | |
TMEM37 Antibody, HRP conjugated |
CSB-PA820182NB01HU | Human | ELISA | 100μl/50μl |
TMEM37 Antibody |
CSB-PA820182NA01HU | Human | ELISA, IF | 100μl/50μl |
What are polyclonal antibodies?
As known to all, Polyclonal Antibodies represent a heterogeneous mix of antibodies from different B cells that recognize multiple epitopes on the same antigen. Each of these individual antibodies recognizes a unique epitope that is located on that antigen.
Polyclonal antibodies vs Monoclonal antibodies
Since polyclonal antibodies are mentioned, monoclonal antibodies are usually never left out. Both polyclonal and monoclonal antibodies have their own features.
Compared with Monoclonal antibodies, the advantages and disadvantages of polyclonal antibody have been presented as follows:
Advantages:
Disadvantages:
DPY30 Antibody cited in "Identification and validation of DPY30 as a prognostic biomarker and tumor immune microenvironment infiltration characterization in esophageal cancer". Oncology letters, 2023
UCP1 Antibody cited in "Peroxisome proliferator-activated receptors-alpha and gamma synergism modulate the gut-adipose tissue axis and mitigate obesity". Molecular and cellular endocrinology, 2023
ATP5F1A Antibody cited in "Electrical stimulation of piezoelectric BaTiO3 coated Ti6Al4V scaffolds promotes anti-inflammatory polarization of macrophages and bone repair via MAPK/JNK inhibition and OXPHOS activation". Biomaterials, 2023
M Antibody cited in "Biochemical monitoring throughout all stages of rabies virus-like particles production by Raman spectroscopy using global models". Journal of biotechnology, 2023
ompA Antibody cited in "Blue Light Sensing BlsA-Mediated Modulation of Meropenem Resistance and Biofilm Formation in Acinetobacter baumannii". mSystems, 2023